BD Medical, a segment of
BD (Becton, Dickinson and Company) BDX, a leading global medical
technology company, announced today the commercial launch of a new passive
needle guard technology, BD UltraSafe PLUS™. The BD UltraSafe PLUS™ Passive
Needle Guard has received 510(k) clearance as an anti-needlestick safety
device.
This product, in addition to offering needlestick safety in an easy-to-use
one-handed device, is enhanced with ergonomic features designed to facilitate
comfort and support for healthcare providers and patients. In addition, this
safety device is designed to meet increasingly complex biotechnology drug
requirements, including higher viscosity.
"We are pleased to offer the new BD UltraSafe PLUS™ Passive Needle Guard which
nicely complements our current safety portfolio," said Claude Dartiguelongue,
President, BD Medical - Pharmaceutical Systems. "We now have an ergonomic
safety device solution for those customers seeking to offer patients the
ability to manually control their injection."
The BD UltraSafe PLUS™ Passive Needle Guard provides many advanced features
including a robust plunger rod to help support injection of viscous drugs, a
larger drug inspection window to improve drug visibility, extended built-in
finger flanges and an enhanced plunger head for improved injection support and
stability. These ergonomic improvements provide support for all users,
including patients with diminished manual dexterity. BD recently conducted a
clinical focus group with patients who had reduced dexterity and also suffered
from rheumatoid arthritis and multiple sclerosis. Subjects reported that the
BD UltraSafe PLUS™ Passive Needle Guard provided ease of use with 100% of
injections executed successfully.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in